Activation of Protease Activated Receptor-2 Induces Delayed Cardioprotection in Anesthetized Mice

  • Shiang Y. Lim
  • Cherry L. Wainwright
  • Simon Kennedy
  • Kathleen A. Kane
Letter to the Editor

Key words

PAR2 ischemia reperfusion mice 


  1. 1.
    Bucci M, Roviezzo F, Cirino G. Protease-activated receptor-2 (PAR2) in cardiovascular system. Vascul Pharmacol 2005;43:247–53.CrossRefPubMedGoogle Scholar
  2. 2.
    Jiang R, Zatta AJ, Kin H, et al. PAR2 activation at the time of reperfusion salvages myocardium via an ERK 1/2 pathway in in vivo rat hearts. Am J Physiol Heart Circ Physiol. 2007;in press.Google Scholar
  3. 3.
    Napoli C, Cicala C, Wallace JL, et al. Protease-activated receptor-2 modulates myocardial ischemia–reperfusion injury in the rat heart. Proc Natl Acad Sci U S A 2000;97:3678–83.CrossRefPubMedGoogle Scholar
  4. 4.
    Napoli C, de Nigris F, Cicala C, et al. Protease-activated receptor-2 activation improves efficiency of experimental ischemic preconditioning. Am J Physiol Heart Circ Physiol 2002;282:H2004–10.PubMedGoogle Scholar
  5. 5.
    Lim SY, Davidson SM, Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: The essential role of the mitochondrial permeability transition pore. Cardiovasc Res 2007;75:530–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Guo Y, Stein AB, Wu WJ, et al. Late preconditioning induced by NO donors, adenosine A(1) receptor agonists, and delta(1)-opioid receptor agonists is mediated by iNOS. Am J Physiol Heart Circ Physiol 2005;289:H2251–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Cattaruzza F, Cenac N, Barocelli E, et al. Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents. Am J Pathol 2006;169:177–88.CrossRefPubMedGoogle Scholar
  8. 8.
    Alshurafa HN, Stenton GR, Wallace JL, Hollenberg MD, Befus AD, Vliagoftis H. A protease activated receptor-2 (PAR-2) activating peptide, tc-LIGRLO-NH2, induces protease release from mast cells: role in TNF degradation. BMC Pharmacol 2004;4:12.CrossRefPubMedGoogle Scholar
  9. 9.
    Stenton GR, Nohara O, Dery RE, et al. Proteinase-activated receptor (PAR)-1 and-2 agonists induce mediator release from mast cells by pathways distinct from PAR-1 and PAR-2. J Pharmacol Exp Ther 2002;302:466–74.CrossRefPubMedGoogle Scholar
  10. 10.
    Parikh V, Singh M. Possible role of cardiac mast cell degranulation and preservation of nitric oxide release in isolated rat heart subjected to ischaemic preconditioning. Mol Cell Biochem 1999;199:1–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Shiang Y. Lim
    • 1
  • Cherry L. Wainwright
    • 2
  • Simon Kennedy
    • 3
  • Kathleen A. Kane
    • 4
  1. 1.The Hatter Cardiovascular InstituteUniversity College London Hospital and Medical SchoolLondonUK
  2. 2.School of PharmacyThe Robert Gordon UniversityAberdeenUK
  3. 3.Faculty of Biomedical and Life SciencesUniversity of GlasgowGlasgowUK
  4. 4.Strathclyde Institute of Pharmacy and Biomedical SciencesUniversity of StrathclydeGlasgowUK

Personalised recommendations